Phase II evaluation of Dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

OBJECTIVE: Preclinical data suggest an important role for the sarcoma proto-oncogene tyrosine kinase (SRC) in the oncogenesis of epithelial ovarian cancer (EOC) or primary peritoneal carcinoma (PPC). The Gynecologic Oncology Group (GOG) conducted a Phase II trial to evaluate the efficacy and safety...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schilder, Russell J., Brady, William E., Lankes, Heather A., Fiorica, James V., Shahin, Mark S., Zhou, Xun C., Mannel, Robert S., Pathak, Harsh B., Hu, Wei, Alpaugh, R. Katherine, Sood, Anil K., Godwin, Andrew K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3748717/
https://ncbi.nlm.nih.gov/pubmed/22710075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2012.06.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados